A stock sale and confusion regarding its parent company are factors dragging down the stock.
Any euphoria after the biotech stock's big jump yesterday didn't last long.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...
The company is walling off subsidiary Scilex from its bankruptcy proceedings.
/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...
The heavy selling pressure might have exhausted for Sorrento Therapeutics (SRNE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street...
A bankruptcy filing is weighing on the drugmaker's shares today.
Wall Street is bullish on these two beaten-down healthcare stocks.
Here is how AMN Healthcare Services (AMN) and Sorrento Therapeutics (SRNE) have performed compared to their sector so far this year.